Decontee Jimmeh
Neurology · Hoover, ALNPI 1366659229
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,637 of the $8,372 with a category attached, or 67.3%. AbbVie accounts for 84.0% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2020 at $7,306 and has fallen 99.2% since, to $57 in 2022.
Across 111 payments — averaging $75.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Amgen$151
- Supernus Pharmaceuticals, Inc.$132
- Lilly USA, LLC$115
- Novartis$110
- Scilex Pharmaceuticals Inc.$107
- plus $722 from 21 others
What the payments were for
- Speaking & faculty fees$5,63767%
- Travel & lodging$93611%
- Food & beverage$1,79921%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $7,036 |
| Amgen | 9 | $151 |
| Supernus Pharmaceuticals, Inc. | 15 | $132 |
| Lilly USA, LLC | 8 | $115 |
| Novartis | 6 | $110 |
| Scilex Pharmaceuticals Inc. | 6 | $107 |
| Tersera Therapeutics LLC | 4 | $82 |
| Avanir Pharmaceuticals, Inc. | 4 | $69 |
| Biodelivery Sciences International, Inc. | 3 | $66 |
| Upsher-smith Laboratories LLC | 3 | $63 |
| Collegium Pharmaceutical, Inc. | 4 | $59 |
| Sentynl Therapeutics, Inc. | 4 | $52 |
| Daiichi Sankyo Inc. | 3 | $42 |
| Acorda Therapeutics, Inc | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 3 | $36 |
| Pfizer | 2 | $27 |
| MDD US Operations, LLC | 2 | $27 |
| Akcea Therapeutics, Inc. | 1 | $25 |
| Nevro Corp. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Forte Bio-pharma LLC | 1 | $14 |
| Flowonix Medical Incorporated | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Assertio Therapeutics, Inc. | 1 | $12 |
| Promius Pharma LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$6,683
How this compares
$8,372 in reported general payments places this provider in the 65th percentile of 255 neurology providers in Alabama.
Other neurology in Hoover
- Diane CounceBirmingham$895K
- Daniel DeesMobile$799K
- Christopher LagankeCullman$711K
- Hayden LongMobile$386K
- Harry McDarisHuntsville$307K
- Belinda Savage-EdwardsHuntsville$296K
- Emily RiserBirmingham$231K
- Nojan ValadiOpelika$219K
- Charles MarkleMobile$212K
- Timothy PrestleyTuscaloosa$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.